Why We Invested In Iaso.ai — High Quality Telemedicine

2 min read

Excited to announce our seed investment alongside Healthy.vc, Refactor Capital and Esther Dyson in Iaso.ai which helps reduce variability and increase quality of telehealth consultations. Tau Ventures is an AI-first fund in Silicon Valley investing primarily in mature seed, typically when there is a pipeline of customers, but we occasionally take earlier or later bets when we see immense promise. Iaso falls on that first exception, having been just founded in 2021, but impressing us with (1) addressing a strong need, (2) building an execution-focused team, and (3) creating a differentiated product. 1) The Need Telehealth was already significant before…...

This article is free to read

Login to read the full article


OR

By subscribing to our main site, you will also be subscribed to DDIntel - our regular letter showcasing our featured articles and applications.

Amit Garg I have been in Silicon Valley for 20 years -- at Samsung NEXT Ventures, running my own startup (as of May 2019 a series D that has raised $120M and valued at $450M), at Norwest Ventures, and doing product and analytics at Google. My academic training is BS in computer science and MS in biomedical informatics, both from Stanford, and MBA from Harvard. I speak natively 3 languages, live carbon-neutral, am a 70.3 Ironman finisher, and have built a hospital in rural India serving 100,000 people.